儿童严重喘多学科护理:一个比较结果分析
Adam S Price1,2, Akilah A Jefferson-Shah1,2, Robert D Pesek1,2
1Allergy Immunology Division, the Department of Pediatrics, the University of Arkansas for Medical Sciences, Little Rock, Ark.
The journal of allergy and clinical immunology. Global
|February 26, 2025
概括
与单一学科诊所 (SDC) 相比,多学科重症喘诊所 (SAC) 在儿科患者中显著减少了急性医疗保健的使用. SACs改善了患有严重喘的高风险儿童的结果.
科学领域:
- 儿科肺病学 儿科肺病学
- 喘管理 喘管理
- 医疗保健的不平等 医疗保健的不平等
背景情况:
- 关于多学科重症喘诊所 (SAC) 与单学科诊所 (SDC) 对儿科重症喘的有效性存在有限的比较数据.
- 在儿童中,严重的喘具有显著的发病率,特别是在某些人口群体中.
研究的目的:
- 在SACs和SDCs治疗的儿科患者之间比较喘结果.
- 检查在SACs中管理的严重喘患者的纵向健康结果.
主要方法:
- 一项回顾性队列研究比较了2018-2022年间在多学科SAC治疗的儿科重症喘患者 (5-18岁) 与SDC治疗的SDC.
- 主要结局是急性医疗利用 (住院治疗,急救访问);次要结局包括全身皮质类固醇和控制药物的使用.
- 长度结局 (医疗保健利用,症状控制,螺旋计) 被评估为12个月的SAC入学前后.
主要成果:
- 该研究包括280名患者;SAC患者更有可能是黑人,并且具有更高的基线发病率.
- 在12个月内,SAC招生与急性恶化 (35到8),住院 (21到1) 和ICU入院 (8到1) 的显著减少有关.
- 在SAC招募后,系统性皮质类固醇处方和急诊室访问的显著下降也被观察到.
结论:
- 多学科重症喘诊所在降低高风险儿科重症喘患者医疗利用率方面具有显著价值.
- 针对性,多学科的护理方法对于改善治疗结果和管理易受伤害的儿童群体中严重喘至关重要.
- 这些发现强调了解决严重儿科喘管理中的医疗保健差异的重要性.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K
Asthma-IV: Nursing Management
2.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
2.9K
COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
226
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
226
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


